Roche Pharma commits 1.5 billion Swiss franc investment in India over next five years
New Delhi: Swiss healthcare giant Roche Pharma has announced a major investment plan of 1.5 billion Swiss Francs in India over the next five years. The company’s commitment was revealed by Francois du Toit, Roche Pharma’s Area Head for Central Eastern Europe, Turkey, Russia, and the Indian Subcontinent, during his speech at the Prosperity Summit.
Du Toit emphasized that this significant investment highlights Roche’s long-term commitment to the Indian market.
“We currently have over 5,000 employees in India. We commit to investing 1.5 billion Swiss Francs at a minimum into our core businesses over the next five years,” du Toit said.
The company sees India not only as an important market, but also as a hub for innovation, he added.
The company’s investment will go into three critical areas, including R&D, he said.
Roche would also be working with Ayushman Bharat and several other schemes to bring its innovative products to as many patients in India as possible, he added.
India’s free trade agreement (FTA) with the four-nation bloc, the European Free Trade Association (EFTA), comes into effect from Wednesday.
Facebook Comments
